Screener
NeoGenomics NEO Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.9B.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
FAQ
- What is NeoGenomics's market capitalization?
- NeoGenomics (NEO) reported market capitalization of $1.9B in Q2 2026.
- How has NeoGenomics's market capitalization changed year-over-year?
- NeoGenomics's market capitalization increased by 104.2% year-over-year, from $930.46M to $1.9B.
- What is the long-term trend for NeoGenomics's market capitalization?
- Over 5 years (2020 to 2025), NeoGenomics's market capitalization has grown at a -24.6% compound annual growth rate (CAGR), from $6.26B to $1.52B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about NeoGenomics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude